glp-1 safety concerns The science of safety: adverse effects of receptor agonists as glucose-lowering and obesity medications Safety risks in the GLP-1

A novel mouse model of glucagon-like peptide-1 receptor expression: a look at the brain

H.et al (2017)

This combination therapy provides a similar glycemic control as compared with intensive insulin regimen, associated with lower risk of hypoglycemia and weight gain [17]

Nathan DM, Lachin JM, Bebu I, Burch HB, Buse JB, Cherrington AL, Fortmann SP, Green JB, Kahn SE, Kirkman MS, Krause-Steinrauf H, Larkin ME, Phillips LS, Pop-Busui R, Steffes M, Tiktin M, Tripputi M, Wexler DJ, Younes N

Frequently shifting your injection timing can cause unpredictable medication levels and reduce weight loss effectiveness

Subsequently, 490 articles underwent preliminary screening based on title and abstract for inclusion/exclusion criteria assessment